Modulation of Innate Immunity by G-CSF and Inflammatory Response by LBPK95A Improves the Outcome of Sepsis in a Rat Model.

Conclusion: Our results revealed that increasing innate immunity by G-CSF pretreatment and decreasing inflammatory responses using LBPK95A improved the survival rates in a rat sepsis model and could be a novel strategy to treat sepsis. PMID: 30525057 [PubMed - in process] (Source: Journal of Immunology Research)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2BkbYgM